CC
MRO

Callan Capital’s Marathon Oil Corporation MRO Stock Holding History

Callan Capital’s Portfolio MRO Stock Details MRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,372
Closed -$276K – 376
2024
Q3 		$276K Sell
10,372
-101
-1% -$2.79K 0.02% 278
2024
Q2 		$300K Sell
10,473
-37
-0.4% -$1.03K 0.02% 236
2024
Q1 		$298K Buy
+10,510
New +$254K 0.03% 207
2023
Q4 		– Sell
-11,463
Closed -$307K – 250
2023
Q3 		$307K Buy
11,463
+263
+2% +$6.8K 0.03% 155
2023
Q2 		$258K Buy
+11,200
New +$264K 0.03% 157

Other funds holding MRO

BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
KRSITF
Kentucky Retirement Systems Insurance Trust Fund Frankfort, Kentucky $1.67B AUM 39.1% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MFS
Mattson Financial Services Kentwood, Michigan $478M AUM 21.36% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Callan Capital's MRO Position: Q4 2024 in Review

Callan Capital sold out of Marathon Oil Corporation (MRO) in Q4 2024, closing a stake of 10,372 shares — an estimated $276K sold.

Callan Capital first reported a position in MRO in Q2 2023 and held it in 5 quarters. The position peaked at $307K in Q3 2023. 6 funds tracked by Wall St. Rank hold MRO as of Q4 2024.

  • Callan Capital reported no remaining Marathon Oil Corporation position as of Q4 2024 after selling out during the quarter.
  • Callan Capital sold 10,372 Marathon Oil Corporation shares in Q4 2024, an estimated $276K.
  • Callan Capital first reported a position in Marathon Oil Corporation in Q2 2023 and held it in 5 quarters.
  • Callan Capital's Marathon Oil Corporation position peaked at $307K in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Marathon Oil Corporation as of Q4 2024.

Based on Callan Capital's 13F filing for Q4 2024, filed 3 Feb 2025.